share_log

HC Wainwright & Co. Maintains Buy on First Wave BioPharma, Lowers Price Target to $14

Benzinga ·  Apr 5, 2023 06:34

HC Wainwright & Co. analyst Yi Chen maintains First Wave BioPharma (NASDAQ:FWBI) with a Buy and lowers the price target from $18 to $14.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment